Medication info
Glimepiride Tablet 2mg (Glimepiride)

Glimepiride Tablet 2mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201801110 · Approved 2018.03.12 · Insurance code 649701720

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant treatment with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previously administered drug should be considered. 4) Dose titration During treatment with this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be closely monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is administered concomitantly with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Disturbance in blood sugar control in patients with type 2 diabetes
View approved original text

This drug serves to aid in blood sugar control for patients with type 2 diabetes through dietary and exercise therapy. It can be used alone or in combination with insulin or metformin when adequate blood sugar control is not achieved with oral antidiabetic agents. Additionally, if blood sugar control is insufficient with sulfonylureas or metformin monotherapy, this drug can be administered alongside metformin to enhance effectiveness. Therefore, this drug is used as an effective treatment for improving blood sugar management.

How to take

Adult dose

Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant treatment with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previously administered drug should be considered. 4) Dose titration During treatment with this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be closely monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is administered concomitantly with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This drug should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Patients allergic to this drug or its components, or to sulfonylureas, should also not receive this medication. As there is no experience using this drug in patients with severely impaired liver or kidney function, insulin therapy is recommended in such cases. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this drug. It is advisable to opt for insulin therapy instead of this drug in cases of severe infections, before and after surgery, or after significant injury. Patients with gastrointestinal disturbances such as diarrhea or vomiting are at risk of hypoglycemia due to improper nutrient absorption and should be cautious. This drug contains lactose, so patients with lactose intolerance or inherited lactose metabolism disorders should not take it. During the first week of taking this medication, the risk of hypoglycemia is increased, so blood sugar levels should be frequently monitored. Elderly patients, those in poor nutritional status, patients with irregular meals, those who frequently consume alcohol, and those with impaired liver or kidney function are at even higher risk of hypoglycemia, so careful management is necessary. This drug contains the dye Yellow No. 4; patients allergic to this component should be cautious. When taking this drug, it is important to be aware of hypoglycemia symptoms, and if hypoglycemia occurs, sugars should be consumed immediately to control it. Hypoglycemia symptoms may include headache, extreme hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. If such symptoms occur, immediate action should be taken. Occasionally, abnormal liver function or changes in blood cell counts or allergic reactions may occur, so any unusual symptoms should be reported to a healthcare provider immediately. This drug should be taken regularly, and dietary and exercise therapies should be implemented together for optimal blood sugar control. When taking other medications, they may affect blood sugar control, so it's important to discuss all medications with a healthcare professional or pharmacist. In particular, blood sugar changes may occur when combined with beta-blockers, certain antibiotics, or steroids. Pregnant or breastfeeding women should not take this drug and should switch to insulin therapy if necessary. For children under 18 years of age, safety and efficacy have not been established, so use should be avoided. Elderly individuals often have decreased kidney function, so dosages should be adjusted and taken with caution. If overdose occurs, severe hypoglycemia may arise, requiring immediate emergency treatment and appropriate measures according to a doctor's instructions. This drug should be kept out of reach of children and stored in its original container for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental disturbance, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.